Abinopharm, Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Efficacy and Safety of NMN as an Anti-ageing Supplement in Middle Aged and Older (40-65 Years) Adults (NCT04823260) | Abinopharm, Inc | 2021-05-25 |
Track Abinopharm, Inc automatically
Every clearance here is in the API, with alerts when new ones post.